HKD 2.84
(1.43%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 3.32 Billion CNY | -22.23% |
2022 | 4.27 Billion CNY | -22.69% |
2021 | 5.53 Billion CNY | 71.56% |
2020 | 3.22 Billion CNY | 24.8% |
2019 | 2.58 Billion CNY | -24.25% |
2018 | 3.4 Billion CNY | 70.05% |
2017 | 2 Billion CNY | 106.0% |
2016 | 973.41 Million CNY | 88.92% |
2015 | 515.24 Million CNY | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 927.32 Million CNY | 1.24% |
2024 Q2 | 927.32 Million CNY | 0.0% |
2023 Q1 | 746.48 Million CNY | 18.28% |
2023 FY | 3.32 Billion CNY | -22.23% |
2023 Q4 | 915.98 Million CNY | 0.0% |
2023 Q3 | 915.98 Million CNY | 22.71% |
2023 Q2 | 746.48 Million CNY | 0.0% |
2022 Q1 | 1.5 Billion CNY | 29.94% |
2022 Q4 | 631.1 Million CNY | 0.0% |
2022 FY | 4.27 Billion CNY | -22.69% |
2022 Q3 | 631.1 Million CNY | -58.11% |
2022 Q2 | 1.5 Billion CNY | 0.0% |
2021 Q2 | 1.6 Billion CNY | 0.0% |
2021 FY | 5.53 Billion CNY | 71.56% |
2021 Q1 | 1.6 Billion CNY | 55.44% |
2021 Q3 | 1.15 Billion CNY | -27.8% |
2021 Q4 | 1.15 Billion CNY | 0.0% |
2020 FY | 3.22 Billion CNY | 24.8% |
2020 Q4 | 1.03 Billion CNY | 0.0% |
2020 Q3 | 1.03 Billion CNY | 78.55% |
2020 Q2 | 578.6 Million CNY | 0.0% |
2020 Q1 | 578.6 Million CNY | -1.13% |
2019 Q2 | 706.26 Million CNY | 0.0% |
2019 FY | 2.58 Billion CNY | -24.25% |
2019 Q1 | 706.26 Million CNY | -25.84% |
2019 Q4 | 585.18 Million CNY | 0.0% |
2019 Q3 | 585.18 Million CNY | -17.14% |
2018 Q1 | 681.95 Million CNY | 39.91% |
2018 Q2 | 681.95 Million CNY | 0.0% |
2018 Q3 | 1.09 Billion CNY | 60.36% |
2018 Q4 | 952.41 Million CNY | -12.91% |
2018 FY | 3.4 Billion CNY | 70.05% |
2017 Q4 | 487.44 Million CNY | 0.0% |
2017 FY | 2 Billion CNY | 106.0% |
2016 FY | 973.41 Million CNY | 88.92% |
2015 FY | 515.24 Million CNY | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Wai Chun Bio-Technology Limited | 50.41 Million HKD | -6495.422% |
Lee & Man Chemical Company Limited | 1.06 Billion HKD | -213.033% |